# Prospective Study on HIV-related Hodgkin Lymphoma

> **NCT01468740** · PHASE2 · UNKNOWN · sponsor: **Harlachinger Krebshilfe e.V.** · enrollment: 130 (estimated)

## Conditions studied

- HIV-associated Hodgkin Lymphoma

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Bleomycin
- **DRUG:** Vinblastine
- **DRUG:** Dacarbazine
- **DRUG:** Etoposide
- **DRUG:** Cyclophosphamide
- **DRUG:** Vincristine
- **DRUG:** Procarbazine
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01468740
- **Lead sponsor:** Harlachinger Krebshilfe e.V.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-07
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2011-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468740, "Prospective Study on HIV-related Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01468740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*